Template:Implantable Cardioverter Defibrillator ACC/AHA/HRS Guidelines: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) No edit summary |
Tarek Nafee (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | {| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | ||
|- | |||
| colspan="1" style="text-align:center; background:DarkGray" |'''ICD Guidelines<br> Microchapters''' | |||
|- bgcolor="LightGrey" | |||
! | |||
|- bgcolor="Coral" | |- bgcolor="Coral" | ||
! | ! | ||
Revision as of 16:50, 26 October 2016
| ICD Guidelines Microchapters |
| Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities |
| Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials |
|
ICD Implantation in the Context of an Abnormal Troponin that is Not Due to a Myocardial Infarction |
|
[[ICD <9 months from diagnosis of nonischemic cardiomyopathy|ICD Implantation <9 Months From The Initial Diagnosis of Nonischemic Cardiomyopathy]] |